Zeon Corporation Zeon Corporation (Zeon; head office: Chiyoda-ku, Tokyo; President and CEO: Tetsuya Toyoshima) is pleased to announce it has acquired patents for Deterministic Cell Separation*¹ (DCS) technology, previously owned by U.S.-based GPB Scientific, Inc., commonly referred to as Curate Bioscience. Leveraging DCS technology, Zeon will pursue new business opportunities in the cell therapy fields. […]

Brno, Czech Republic — Tescan Group today announced the acquisition of FemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicated Laser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The new unit expands Tescan’s correlative and multimodal portfolio for semiconductor, biomedical device manufacturing, and […]

Brno, Czech Republic — Tescan Group today announced the acquisition of FemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicated Laser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The new unit expands Tescan’s correlative and multimodal portfolio for semiconductor, biomedical device manufacturing, and […]

LIVERMORE, Calif. — Today, Precision Cell Systems (PCS) announced its official launch following the strategic acquisitions of S2 Genomics and ORFLO, creating a unified company that addresses critical bottlenecks in cell analysis workflows. PCS launches with significant market traction: over 1,000 installed instruments, more than 700 active customers, and a technology portfolio validated by over 500 […]

Strategic partnership accelerates the company’s mission to transform pharmaceutical R&D Solana Beach, CA — Scientist.com, the leading AI-enabled R&D orchestration platform for the life sciences industry, today announced that it has entered into a definitive agreement to be acquired by GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare. This milestone transaction validates […]

Transaction underscores GHO’s strategy of backing category leaders across preclinical and clinical R&D services Scientist.com is the market-leading digital platform for outsourced R&D, trusted by the world’s top biopharma companies and thousands of pre-vetted suppliers of scientific services and products. GHO’s deep sector knowledge and proven record of scaling life sciences businesses will accelerate Scientist.com’s […]

San Diego, CA – Genesee Scientific, a leading provider of high-quality, value-driven lab essentials, today announced the acquisition of Jade Scientific, a Michigan-based distributor recognized for its extensive offering of chemicals and consumables to clinical reference, pharma/biotech, and environmental labs nationwide. This strategic acquisition marks a significant milestone in Genesee’s growth journey. Together, the two companies will […]

SciSure acquires Labfolder (ELN) and Labregister (inventory) from LabForward, expanding its Scientific Management Platform for connected science. Berlin, Germany Today, SciSure announced the acquisition of Labfolder and Labregister, two flagship products from Labforward, reinforcing its commitment to create the home base for connected and reproducible science. Why this matters for science This acquisition deepens SciSure’s ability to serve modern laboratories with […]

Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint – servicing over 160 labs in 30+ countries  The acquisition creates the largest global ‘software pure player’ in the clinical genomics space, which will maintain UK presence at the renowned Wellcome Sanger Institute MONTPELLIER, France, and CAMBRIDGE, UK: SeqOne, a pioneer in […]

Highly Complementary Technologies Strengthen Thermo Fisher’s Portfolio in Bioprocessing and Adjacent Markets WALTHAM, Mass. —  Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction […]